Hepatite B crônica: progressão da doença, complicações e estratégias terapêuticas — uma revisão narrativa da literatura
Year: 2026
Type: article
Abstract: Chronic hepatitis B is an important public health problem due to its potential to progress to liver fibrosis, cirrhosis, and hepatocellular carcinoma. Disease progression is influenced by viral, immunological, clínical, metabolic, and host-related factors, as well as by conditions associated with diagnosis, treatment, and follow-up. This study aimed to analyze the available evidence on the clinical progression of chronic hepatitis B, its main associated factors, complications, and therapeutic strategies. This is a narrative literature review based on searches conducted in PubMed/MEDLINE, LILACS, and SciELO, considering publications from January 2015 to July 2026 in Portuguese, English, and Spanish. Scientific studies, clinical guidelines, and technical and normative documents addressing the natural history of infection, factors associated with disease progression, complications, and treatment were prioritized. The literature indicates that the progression of chronic hepatitis B results from the interaction between viral replication, immune response, and host characteristics, and may also be influenced by coinfections, alcohol consumption, metabolic disorders, and conditions affecting access to healthcare. Antiviral therapy plays a central role in suppressing viral replication and reducing the risk of disease progression, whereas longitudinal follow-up remains essential for identifying complications and stratifying risk. In conclusion, the management of chronic hepatitis B requires an integrated approach involving prevention, early diagnosis, individualized assessment, timely treatment, and continuous follow-up.
Source: Revista fisio&terapia.
DOI: 10.69849/b0pcxt38
Institution: Faculdades Integradas Aparício Carvalho
Language: English
Topic: Hepatitis B Virus Studies
Subfield: Epidemiology
Field: Medicine
Domain: Health Sciences
Keywords: chronic hepatitis B, disease progression, liver fibrosis, liver cirrhosis, hepatocellular carcinoma, antiviral therapy, viral replication, immune response, co-infection, alcohol consumption, metabolic disorders, risk factors, natural history of infection, longitudinal follow-up, risk stratification
Open Access status: hybrid
OpenAlex ID: W7225724997
